Convatec Technologies, Inc.

Synovo Gmbh

Qualizyme Diagnostics Gmbh and Co Kg

Lucy Louisa Ballamy

Wayne Lee Bonnefin

David Parsons

Sarah Wroe

Michael W Burnet

Garry Storey

Philip Godfrey Bowler

Daniel Gary Metcalf

Daniel Luschnig

Joseph Thompson

Marion Herbe

Mohammad Forhad Hossain

Hugh R Gong

Sharon Lam Po Tang

Alan Rogers

Sean Kelly

Clemens Gamerith

Eva Sigi

Andrea Heinzle

Jade Steven

Vitaliy V Khutoryanskiy

Michael Burnet

Andrew Heinzle

Antibacterial nanofibres and methods for their preparation are described. Antibacterial nanofibres include as-spun alginate nanofibres treated with silver to generate silver-alginate nanofibres. Antibacterial nanofibres provided are useful components of wound dressings, wherein the wound dressings optionally further comprise malodor absorbing agents such as cyclodextrins.

Antibacterial nanofibres

Embodiments described herein relate to compounds for the detection of wounds, e.g., chronic wounds or infected wounds, including compositions, substrates, kits, dressing materials, and articles, and systems containing such compounds. Further embodiments relate to methods of using these compositions, kits and systems in diagnostic assays, and in the diagnosis and/or detection of chronic or infected wounds based on enzymatic conversion of specific substrates which are contained in the compositions. Additional embodiments relate to methods of characterizing wounds based on expression of a plurality of markers and using such information to treat, manage, and follow-up patients suffering from chronic or infected wounds.

Modified wound dressings

Multi component fibres for the reduction of the damaging activity of wound exudate components such as protein degrading enzymes and inflammatory mediators in wounds, the fibres comprising: from 10% to 100% by weight of the fibres of pectin and a sacrificial proteinaceous material in a weight ratio of 100:0 to 10:90 pectin to sacrificial proteinaceous material and from 0% to 90% by weight of the fibres of another polysaccharide or a water soluble polymer.

Fibres, a process for producing such fibres and a wound dressing incorporating them

Provided herein are microbial infection indicator devices, including dressing with indicators, standalone indicator inserts or disks that can be freely placed at a wound site or dressing, and applications thereof for displaying a visible or detectable signal to a user upon detection of an analyte or biomarker indicative of an infection, such as a color change.

Detecting microbial infections in wounds

A chemically modified cellulosic fibre or filament having a moisture content of at least 7% by weight obtained by a process comprising the steps of (i) obtaining cellulosic fibres or filament and chemically modifying the cellulose by substitution to increase its absorbency; (ii) washing the fibres after step (i) in a mixture comprising water and up to 99% by weight of water-miscible organic solvent; (iii) drying the fibres to a moisture content of at least 7% by weight.

Processing of chemically modified cellulosic fibres

The invention relates to a chemically modified cellulose based dressing particularly for use in the dressing of wounds but also for use as a packing material. Dressings according to the invention seek to mitigate the problems associated with shrinkage encountered with fibrous dressings made of gel-forming fibres and comprise a compressed body of chemically modified polysaccharide having a density of at least 0.08 g/cm.

Dressing

Growing community of inventors

Flintshire, United Kingdom

Lucy Louisa Ballamy